Elucidating the biological mechanism of myriocin has therefore been an area of active research. Initial studies have demonstrated that myriocin is mechanistically distinct from FKS06 and cyclosporin A. It does not block interleukin 2 (IL-Z) production by antigen-or mitogen-stimulated T cells. but potently inhibits the proliferation of CTLL-2 cells, a murine cytotoxic T lymphocyte line that is IL-2 dependent [3] . Although this observation initially prompted speculation that myriocin might specifically abrogate IL-2 receptor-mediated signaling, subsequent studies by Nakamura et aL [7] and our laboratory (data not shown) indicate otherwise. Many transformed ccl1 lines, including several other IL-2 dependent cell types, are not affected by myriocin, suggesting that myriocin is merely specific for certain lymphocyte lineages. Structural similarities between myriocin and sphingosine-derived molecules also suggest that myriocin might perturb sphingolipid biosynthetic or signaling pathways, and experimental support for this hypothesis has been obtained by two independent laboratories. Riezman and coworkers [8] reported that myriocin abrogates ceramide synthesis in Saccharoq~ces mwisiae and ultimately causes cell death. A more precise mechanism for this general effect on ceramide production was then determined by Miyake et al. [9] , who established that myriocin inhibits a serine palmitoyltransferase (SPT) activity that can be detected in CTLL-Z-derived microsomes with an inhibition constant of 280 PM. SPT is a membrane-associated activity that catalyzes the formation of 3-ketodihydrosphingosine from serine and palmitoyl CoA in a pyridoxal 5'-phosphate (PLPJ-dependent manner ( Figure 1) [lo-141. Because SPT is the rate-limiting step in sphingolipid biosynthesis ( Figure 2 ) and sphingolipid metabolites are important mediators of cellular proliferation and programmed cell death, it is conceivable that myriocin-induced perturbations might degrade the cellular immune response. In agreement with this hypothesis, micromolar concentrations of dihydrosphingosine, sphingosine or sphingosine l-phosphate -downstream metabolites in the biosynthetic pathway -are able to suppress the effects of myriocin on CTLL-2 cells [9] . Sphingomyelinase and CZ-ceramide also effect partial restoration of cell proliferation.
Of these compounds, sphingosine lphosphate rescues the cells most effectively, and more recent studies have extended these findings, revealing that myriocin actually induces CTLL-2 programmed cell death and that high levels of exogenous sphingosine can also cause apoptosis [7] . These mechanistic ambiguities are exacerbated by the biological properties of myriocin-related compounds. Structural analogs such as Z-alkyl-Z-amino-1,3-propanediols, FTY720 (2; Figure 1 ) and Z-substituted-Z-aminoethanols are equipotent to myriocin in MLR and skin-allograft assays but do not inhibit SPT [19, 20] prevent CTLL-2 proliferation at concentrations up to 5 @I. To confirm further that the iv-and Cl-linker compounds (16 and 21) are functionally equivalent to myriocin, both derivatives were then assayed for their ability to inhibit SPT activity in CTLL-Z-derived microsomes ( Figure 8 ). hlyriocin potently inhibits this process with an IC,, of 0.28 r&l, and both .V-and Cl-linker myriocin have IC,, values of -200 nM. CZO-linker myriocin (4) has no significant effect on SPT activ-it);, even at micromolar concentrations.
These results correlate with the antiproliferative activities of myriocin and its derivatives and indicate that the pentaethylene glycol-modified compounds are suitable probes for myriocin-binding proteins. It is noted, however, that X-and Cl-modifications of myriocin attenuate its ability to abrogate SPT activity more substantially than they affect its ability to induce CTLL-2 apoptosis. This effect might reflect differences in the biophysical properties of myriocin and its derivatives (such as membrane permeability) or the existence of multiple myriocin targets in CTLL-2 cells.
Synthesis of myriocin affinity matrices
The preparation of affinity matrices containing the N-and Cl-linker derivatives was then carried out using cross-linked agarose resins. Our original plan was to liberate the thiol groups in 16 and 21 by metal-ammonia reduction of the benzyl groups. Unfortunately, both sodium-and calciummediated deprotections resulted in complex mixtures, and new thiol protecting groups had to be used. The N-linker myriocin compound was therefore redesigned as the S-acetyl lactone (28), using chemical transformations analogous to those used in the synthesis of 20 ( Figure 9 ). LiOH saponification of 28 then provided the N-linker myriocin thiol (a), which was reacted with ten equivalents of maleimide-functionalized Affigel 102 (30). Remaining thiol-reactive groups in the matrix were quenched with an excess of P-mercaptoethanol.
Likewise, preparation of the Cl-linker myriocin affinity matrix required the development of new carboxyl-functionalized myriocin derivatives.
Because of the base sensitivity of Cl-linker myriocin, its thiol group was introduced as a trityi thioether for subsequent deprotection by trifluoroacetic acid and triethylsilane.
The Cl4 carbonyl of myriocin WdS also reduced to the secondary alcohol with sodium borohydride prior to unmasking the thiol because trityl deprotection in the presence of the ketone yields an macrocyclic hemiketal that is unreactive with the resin-bound maleimide (data not shown). This structural modification should not affect the ability of Cl-linker myriocin-containing matrices to sequester binding proteins, because myriocin and C14-hydroxy myriocin are equipotent in MLR assays [30] . Maleimide-functionalized agarose (30) was therefore reacted with the Cl-linker myriocin thiol and P-mercaptoethanol to provide the second myriocin affinity matrix (32; Figure lo ), using conditions identical to those for the synthesis of 31.
LJltimately, the efficacy of these myriocin affinity matrices depends upon their capacity for specific protein binding from cell Iysates. To evaluate the macromolecular accessibility of matrices 31 and 32. their ability to sequester SPT activity was examined (see Figure 10 ). The N-linker (31) and Cl-linker (32) myriocin matrices were incubated with detergent-solubilized CTLL-2 microsomes and the resultant supernatant was assayed for SPT activity. These experiments clearly demonstrate that the AT-linker myriocin affinity matrix can deplete cell lysates of the enzymatic activity, whereas a P-mercaptoethanol-derivatized control matrix (33) does not affect soluble SPT levels. Surprisingly, the Cl-linker myriocin matrix has significantly diminished capacity for binding the activity. presumably due to suboptimal ligand presentation on the agarose support. This hypothesis is substantiated by the ability of both myriocin derivatives to deplete SPT activity from cell lysates when they are conjugated to polydimethylacrylamide beads (data not shown). Guided by these observations, the N-linker myriocin matrix (31) was selected for further studies i n conjunction with CTLL-2 lysates. Regardless of the cellular fraction, the vast majority of matrix-associated proteins are nonspecific in nature, consistent with the hydrophobic character of this natural product. Two polypeptides, however, are specific myriocin-binding proteins with apparent molecular weights of 51 and 5S kDa ( Figure  11 ). These proteins, ~51 and ~5.5, are predominantly associated with the IGEPAL-CA-630-solubilized microsomal fraction, although they also segregate with cytosolic proteins to some degree. This pattern of subcellular localization is reminiscent of previous reports that SPT Figure 12 activity resides in the endoplasmic reticulum and can be membrane-dissociated with nonionic detergents [27, 32] . SPT activities in CTLL-2 subcellular fractions were therefore measured 171 d-o, substantiating this correlation: the highest levels of SPT activity were found in the IGEPAL-C,4-630-solubilized CTLL-2 microsomes and some residual activity was associated with the cytosol (Figure 12 ). Given this empirical correspondence and the apparent masses of the myriocin-binding proteins, it seemed likely that the two polypeptides are identical to murine LCBl and LCB2. could contribute independently to SPT activity by homodimerization, but the absence of a complete PLP-binding site in LCBl argues against this model. In any case, the existence of other catalytic or regulatory SPT components cannot be ruled out even though none was observed in these experiments; myriocin might abrogate 3-ketodihydrosphingosine synthesis by binding a subset of SPT components or by disrupting a larger complex. It is also possible that the affinity chromatography conditions (0.1% detergent, 250 mM NaCl) partially dissociate a larger SPT complex, although SPT retains optimum activity levels in this buffer medium (data not shown).
Consistent with these observations, the ability of myriocin to inhibit SPT is remarkably congruent with the currently accepted mechanism of 3-ketodihydrosphingosine biosynthesis (Figure 14) . Isotopic-labeling studies suggest that the reaction proceeds by sequential imine formation, a-carbon deprotonation, palmitoylation, decarboxylation, protonation and imine hydrolysis [3S] . (This mechanism is in contrast with an otherwise reasonable alternative of imine formation. decarboxylation. palmitoylation and hydrolysis). The observation that serine decarboxylation is palmitoyl CoA-dependent provides additional support for this mechanism and indicates the importance of a C3-ketone for substrate decarboxylation [36] . Furthermore, the conservation of CZ-configuration in serine and 3-ketodihydrosphingosine demands that the a-proton/palmitoyl Co,4 and carboxyl group/proton substitutions proceed by a combination of stereochemical inversion and retention, Within this context, it is likely that the first transformation occurs with inversion of configuration and the second with retention because this sequence would require the least molecular motion in the enzymesubstrate complex. This mechanistic course is also more consistent with the structure of myriocin; the natural product stereochemically matches the putative reaction intermediate preceding decarboxylation (see Figure 14) , and the lack of a C3-keto group in myriocin provides a plauboth cellular processes [38, 39] . The addition of sphingosible basis for its potent inhibitory activity. and a 37°C shaker incubator (250 rpm). The ATCC agar slant was used to innoculate 3 ml of media, and the fungal culture was maintained for 2 days. The 3 ml culture was then added to 100 ml of media, fermented for another 2 days, and then expanded to a final media volume of 1.1 I. After this 1.1 I culture was incubated for 15 days, the mycelial cake was isolated by filtration, washed with water (2 x 75 ml), and extracted with methanol (4 x 75 ml). The methanol extract was subsequently concentrated i n vacua, diluted with an equal volume of water, and appl i ed to a 100 ml column of Amberlite XAD-16 (prewashed with five volumes of methanol and five volumes of water; Sigma, St. Louis, MO).
The hydrophobi c matrix was washed with water (5 x 100 ml), acetone:water:NH,OH
(1:4:0.02; 2 x 100 ml), and methanokwater (1:l; 2 x 100 ml). Myriocin was finally eluted from the column i n methanol: water (4:l ; 50 x 25 ml fractions). Myriocin-containing fractions were pool ed and solvent was removed i n vacua to yield 100-200 mg of crude myriocin (1; at least 90% purity). This crude preparation was used directly i n the syntheses of myriocin derivatives or recrystallized from methanol to provide pure myriocin for biological studies.
Evaluation of myriocin derivatives in CTLL-2 proliferation assay CTLL-2 cells were grown i n cell culture media (RPM1 1640; 10% fetal bovi ne serum, 20 mM HEPES, pH 7.4, 2 mM glutamine, 1 mM sodium pyruvate, 50 pM 8-mercaptoethanol, 100 U/ml penicillin G, 100 yg/ml streptomycin sulfate, 20 U/ml IL-2) i n a 5% CO, and 37' C incubator. Myriocin and its derivatives were maintained as 1 mM, 100 uM, 10 pM and 1 pM stocks i n methanol and stored at -20°C. Using these reagents, a series of 0.5 ml cultures were established i n a 12-well cell culture dish, each containing 25,000 CTLL-2 cells, 1% methanol, and the appropriate myriocin-derived compound at concentrations ranging from 2.5 nM to 5pM.
A well containing only CTLL-2 cells and 1% methanol was also i ncl uded as a control.
The 
